rifampicin, Quantity: 300 mg - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

eviplera tenofovir disoproxil fumarate 300 mg /emtricitabine 200 mg /rilpivirine (as hcl) 25 mg tablet bottle

gilead sciences pty ltd - emtricitabine, quantity: 200 mg; tenofovir disoproxil fumarate, quantity: 300 mg; rilpivirine hydrochloride, quantity: 27.5 mg (equivalent: rilpivirine, qty 25 mg) - tablet, film coated - excipient ingredients: pregelatinised maize starch; microcrystalline cellulose; croscarmellose sodium; polysorbate 20; povidone; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; sunset yellow fcf aluminium lake; triacetin; iron oxide red; macrogol 3350; indigo carmine aluminium lake - eviplera is indicated for the treatment of hiv infection in treatment-na?ve adult patients with plasma hiv-1 rna =< 100,000 copies/ml at the start of therapy. eviplera is also indicated in certain virologically-suppressed (hiv-1 rna <50 copies/ml) adult patients on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see clinical trials). patients must not have a history of resistance to any of the components of eviplera (tenofovir df, emtricitabine or rilpivirine).

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

rifampicin isoniazid tablets film-coated

lupin limited - rifampicin, isoniazid - tablets film-coated - 150mg+ 75mg

rifampicin isoniazid pyrazinamide tablets

lupin limited - rifampicin, isoniazid, pyrazinamide - tablets - 60mg+ 30mg+ 150mg

rifampicin isoniazid pyrazinamide ethambutol hydrochloride tablets film-coated

lupin limited - rifampicin, isoniazid, pyrazinamide, ethambutol (ethambutol hydrochloride) - tablets film-coated - 150mg+ 75mg+ 400mg+ 275mg

rifampicin 60mg-isoniazid 30mg tablets tablets dispersible

lupin limited - rifampicin, isoniazid - tablets dispersible - 60mg+ 30mg

Australia - English - Department of Health (Therapeutic Goods Administration)

paclitaxel ebewe paclitaxel 300 mg/50 ml concentrated injection vial

sandoz pty ltd - paclitaxel, quantity: 300 mg - injection, concentrated - excipient ingredients: peg-35 castor oil; ethanol - primary treatment of ovarian cancer in combination with a platinum agent. treatment of metastatic ovarian cancer and breast cancer, after failure of standard therapy. treatment of non-small cell lung cancer (nsclc). adjuvant treatment of node positive breast cancer administered sequentially to doxorubicin and cyclophosphamide. treatment of metastatic cancer of the breast, in combination with trastuzumab (herceptin), in patients who have tumours that overexpress her-2 and who have not received previous chemotherapy for their previous metastatic disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

viread tenofovir disoproxil fumarate 300mg tablet bottle

gilead sciences pty ltd - tenofovir disoproxil fumarate, quantity: 300 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch; magnesium stearate; titanium dioxide; hypromellose; indigo carmine; triacetin - viread in combination with other antiretroviral agents is indicated for the treatment of hiv-infected adults and paediatric patients 12 years of age and older.,viread is indicated for the treatment of chronic hepatitis b in adults (see clinical trials).,viread is indicated for the treatment of chronic hepatitis b in paediatric patients 12 years of age and older with compensated liver disease and with evidence of immune active disease, i.e. active viral replication, persistently elevated serum alt levels or evidence of active inflammation. viread in combination with other antiretroviral agents is indicated for the treatment of hiv-infected adults. viread is indicated for the treatment of chronic hepatitis b in adults with evidence of active viral replication and active liver inflammation.

Australia - English - Department of Health (Therapeutic Goods Administration)

stocrin efavirenz 300mg tablet bottle

merck sharp & dohme (australia) pty ltd - efavirenz, quantity: 300 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; sodium lauryl sulfate; hyprolose; lactose monohydrate; magnesium stearate; carnauba wax; titanium dioxide; hypromellose; macrogol 400; propylene glycol; indigo carmine; purified water; isopropyl alcohol; cochineal - stocrin is indicated for use in combination with other antiviral agents for the treatment of hiv-1 infection in adults and children. (see clinical trails; use in children)

Australia - English - Department of Health (Therapeutic Goods Administration)

stocrin efavirenz 300mg tablet blister pack

Australia - English - Department of Health (Therapeutic Goods Administration)

trileptal oxcarbazepine 300mg tablet film coated blister pack

novartis pharmaceuticals australia pty ltd - oxcarbazepine, quantity: 300 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; iron oxide yellow; purified talc; crospovidone; hypromellose; macrogol 8000; colloidal anhydrous silica; titanium dioxide; magnesium stearate - trileptal is indicated for use as monotherapy or adjunctive therapy for the treatment of partial seizures and generalised tonic-clonic seizures, in adults and children.